Dennewill James Robert Jr. reported SGP

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002106895-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 5, 2026

Published

Feb 9, 2026

Ingested by INSIDER

Nov 5, 04:18 UTC

Last re-read

Nov 5, 04:18 UTC

Extracted facts

Filer

Dennewill James Robert Jr.

Role

Chief Operating Officer

Transaction

Grant or awardAs filed: “A”

Asset

SpyGlass Pharma, Inc. — Stock Option (right to buy)

Ticker

SGP

Shares

105.0K

Price per share

$0

Execution date (reported)

Feb 5, 2026

Owned after transaction

105.0K shares

Days from execution to publication

4

What this establishes

Dennewill James Robert Jr. filed this Form 4 reporting a grant or award of SGP on Feb 5, 2026. It became public on Feb 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Operating Officer

Dennewill James Robert Jr.cik:0002106895

Issuer

SpyGlass Pharma, Inc.cik:0001778922

Revision history · 0

No field has changed since this record was first ingested.